BARDA Industry Day
BARDA and 98point6 have forged a partnership to accelerate efforts on their comprehensive program of assessment, triage, diagnosis, reporting and tracking of patients infected with SARS-CoV-2. By connecting people with board-certified physicians through the convenience of an easy-to-use mobile app, 98point6 empowers patients to seek and receive care safely from their remote location, preventing the unnecessary spread of infection.With support from BARDA, 98point6 originally developed this diagnostic tool for treating and tracking influenza infections. Using the original diagnostic tool as a springboard for COVID-19, patients with fever or respiratory symptoms receive automated COVID-19 screening via private and secure in-app messaging. 98point6 then creates daily and weekly reports of respiratory illness activity by zip code which will help to identify hot spots. Suspected COVID-19 patients will be directed to testing locations for confirmatory diagnostic testing. This will include a cohort of up to 10,000 patients who will receive access to 98point6 as part of the study. By combining early and rapid healthcare provider assessments with diagnostic antigen and viral testing for SARS-CoV-2 98point6 can provide early indication of regional COVID-19 diagnosis rates.
98point6 has demonstrated near real-time nationwide reporting of respiratory illnesses, enabling more rapid awareness and response by public health organizations. As part of this study, the cohort of up to 10,000 new enrollees, regardless of symptomology, will receive unlimited virtual care visits with 98point6 board-certified physicians at no cost until January 8, 2021. 98point6 can also extend the current nationwide reporting infrastructure to deliver data daily on the number of patients who may be ill and asymptomatic, and those who are ill and have COVID-19 symptoms. 98point6 has the ability to follow up with each individual to continue tracking health changes and outcomes. By better triaging patients through their virtual care platform, 98point6 expects to reduce the load on the larger healthcare system, especially as the flu season draws near.
The following information is provided by the company and does not indicate an endorsement by the federal government of the company or its products.
Founded in 2015 and headquartered in Seattle, 98point6 is pioneering a new approach to primary care. By pairing AI and machine learning with board-certified physicians, our vision is to make primary care more accessible and affordable leading to better health. We meet consumers where they are by offering private, text-based diagnosis and treatment via a mobile app. 98point6 increases primary care utilization among those not actively or appropriately engaged in their health—enabling earlier medical intervention and reducing overall cost of care. For more information about 98point6, visit www.98point6.com.
Share this article now!
This award is one component of BARDA's rapidly expanding COVID-19 medical countermeasure portfolio; visit BARDA's COVID-19 Portfolio to learn more.
Be the first to know about BARDA news and new awards. Sign-up for our email announcements: